| The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling BA Liu, K Jablonowski, M Raina, M Arcé, T Pawson, PD Nash Molecular cell 22, 851-868, 2006 | 409 | 2006 |
| Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling M Clarke, AJ Lohan, B Liu, I Lagkouvardos, S Roy, N Zafar, C Bertelli, ... Genome biology 14 (2), R11, 2013 | 373 | 2013 |
| Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells Y Peng, Q Kang, Q Luo, W Jiang, W Si, BA Liu, HH Luu, JK Park, X Li, ... Journal of Biological Chemistry 279 (31), 32941-32949, 2004 | 282 | 2004 |
| The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo J Chen, S Jin, V Abraham, X Huang, B Liu, MJ Mitten, P Nimmer, X Lin, ... Molecular cancer therapeutics 10 (12), 2340-2349, 2011 | 209 | 2011 |
| Molecular mechanisms of SH2-and PTB-domain-containing proteins in receptor tyrosine kinase signaling MJ Wagner, MM Stacey, BA Liu, T Pawson Cold Spring Harbor perspectives in biology 5 (12), a008987, 2013 | 208 | 2013 |
| High-throughput phosphotyrosine profiling using SH2 domains K Machida, CM Thompson, K Dierck, K Jablonowski, S Kärkkäinen, B Liu, ... Molecular cell 26 (6), 899-915, 2007 | 205 | 2007 |
| Large-scale interaction profiling of PDZ domains through proteomic peptide-phage display using human and viral phage peptidomes Y Ivarsson, R Arnold, M McLaughlin, S Nim, R Joshi, D Ray, B Liu, J Teyra, ... Proceedings of the National Academy of Sciences 111 (7), 2542-2547, 2014 | 181 | 2014 |
| The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction BA Liu, BW Engelmann, PD Nash FEBS letters 586 (17), 2597-2605, 2012 | 163 | 2012 |
| SH2 domains recognize contextual peptide sequence information to determine selectivity BA Liu, K Jablonowski, EE Shah, BW Engelmann, RB Jones, PD Nash Molecular & Cellular Proteomics 9 (11), 2391-2404, 2010 | 148 | 2010 |
| The SH2 Domain-Containing Proteins in 21 Species Establish the Provenance and Scope of Phosphotyrosine Signaling in Eukaryotes BA Liu, E Shah, K Jablonowski, A Stergachis, B Engelmann, PD Nash Science Signaling 4 (202), ra83, 2011 | 126 | 2011 |
| Evolution of SH2 domains and phosphotyrosine signalling networks BA Liu, PD Nash Philosophical Transactions of the Royal Society B: Biological Sciences 367 …, 2012 | 103 | 2012 |
| High‐throughput analysis of peptide‐binding modules BA Liu, B Engelmann, PD Nash Proteomics, 2012 | 63 | 2012 |
| SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome BA Liu, BW Engelmann, K Jablonowski, K Higginbotham, AB Stergachis, ... Cell Communication and Signaling 10 (1), 27, 2012 | 49 | 2012 |
| Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers BA Liu, D Olson, K Snead, J Gosink, EM Tenn, M Zaval, A Cao, D Sahetya, ... Cancer Research 80 (16_Supplement), 5581-5581, 2020 | 35 | 2020 |
| Enfortumab vedotin induces immunogenic cell death, elicits antitumor immune memory, and shows enhanced preclinical activity in combination with immune checkpoint inhibitors D Olson, P Younan, B Liu, G Blahnik-Fagan, J Gosink, K Snead, E Tenn, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 25 | 2022 |
| Selection of recombinant anti‐SH 3 domain antibodies by high‐throughput phage display H Huang, NO Economopoulos, BA Liu, A Uetrecht, J Gu, N Jarvik, ... Protein Science 24 (11), 1890-1900, 2015 | 18 | 2015 |
| Introduction: History of SH2 domains and their applications BA Liu, K Machida SH2 Domains: Methods and Protocols, 3-35, 2017 | 13 | 2017 |
| Vedotin ADCs induce ER stress and elicit hallmarks of ICD across multiple cancer indications K Klussman, EM Tenn, S Higgins, R Mazahreh, K Snead, J Hamilton, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 8 | 2020 |
| Additional mechanisms of action of SGN-CD48A in multiple myeloma and improved antitumor activity in combination with daratumumab DJ Olson, BA Liu, M Zaval, A Cao, J Gurgel, J Cochran, N Stevens, ... Cancer Research 78 (13_Supplement), 5619-5619, 2018 | 5 | 2018 |
| Expression and production of SH2 domain proteins BA Liu, M Ogiue-Ikeda, K Machida SH2 Domains: Methods and Protocols, 117-162, 2017 | 5 | 2017 |
Piers D NashUniversity of ChicagoVerified email at uchicago.edu
